Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (2022)
Chapter: Appendix C: Public Meeting Agendas
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix B: Summary of the Committee's Town Halls
Appendix C
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
Appendix C
Public Meeting Agendas
COMMITTEE ON THE GUIDANCE ON PFAS TESTING AND HEALTH OUTCOMES
The Keck Center, 500 Fifth Street, NW
Washington, DC 20001
FEBRUARY 4, 2021
VIRTUAL MEETING
| 1:00 | Purpose of Open Session and Introduction of Committee Members Bruce N. Calonge, Committee Chair |
| 1:15–2:00 | ATSDR Perspectives on Study Scope, Background, and Objectives Patrick Breysse, Director, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry |
| 2:00–2:45 | NIEHS Perspectives on Study Scope, Background, and Objectives Brian R. Berridge, Scientific Director, Division of the National Toxicology Program, Associate Director, National Toxicology Program |
| 2:45–3:35 | Committee Discusses the Statement of Task with the Sponsor |
| 3:35–3:40 | Break |
| 3:40–3:45 | Instructions for Public Comment Session Bruce N. Calonge |
| 3:45–4:45 | Opportunity for Public Comment on Committee’s Charge (must preregister, 1 person per organization, 3 minutes each) |
| 4:45 | ADJOURN |
APRIL 7, 2021
EASTERN COMMUNITIES TOWN HALL (ATSDR REGIONS I–IV)
VIRTUAL MEETING
| 2:00–2:10 | Welcome and Introductions Bruce N. Calonge, Committee Chair |
SESSION A—Community Perspectives from ATSDR Region I
| 2:10–3:10 | Community Perspectives from ATSDR Region I Alan Woolf, Moderator, Harvard Medical School/Boston Children’s Hospital |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
| 2:10–2:20 | Laurene Allen, Merrimack Citizens for Clean Water |
| 2:20–2:30 | Teresa Gerade, Don’t Undermine Memphremagog’s Purity (DUMP) |
| 2:30–2:40 | Ayesha Khan, Nantucket PFAS Action Group |
| 2:40–2:50 | Kristen Mello, Westfield Residents Advocating For Themselves (WRAFT) |
| 2:50–3:10 | Discussion |
SESSION B—Community Perspectives from ATSDR Region II
| 3:10–3:45 | Community Perspectives from ATSDR Region II Laurel Schaider, Moderator, Silent Spring Institute |
| 3:10–3:20 | Tracy Carluccio, Delaware Riverkeeper Network |
| 3:20–3:30 | Loreen Hackett, PFOA Project New York |
| 3:30–3:45 | Panel Discussion |
| 3:45–3:55 | Break |
SESSION C—Community Perspectives from ATSDR Region III
| 3:55–4:30 | Community Perspectives from ATSDR Region III Maida Galvez, Moderator, Icahn School of Medicine at Mount Sinai |
| 3:55–4:05 | Patrick Elder, Military Poisons |
| 4:05–4:15 | Hope Grosse, Buxmont Coalition for Safe Water |
| 4:15–4:30 | Panel Discussion |
SESSION D—Community Perspectives from ATSDR Region IV
| 4:30–5:40 | Community Perspectives from ATSDR Region IV Linda Birnbaum, Moderator, National Institute of Environmental Health Sciences, National Toxicology Program (retired) |
| 4:30–4:40 | La’Meshia Whittington, North Carolina Black Alliance |
| 4:40–4:50 | Mike Watters, Grays Creek Residents United Against PFAS in our Wells & Rivers |
| 4:50–5:00 | Emily Donovan, Clean Cape Fear |
| 5:00–5:10 | Cheryl Sievers-Cail, South Carolina Indian Affairs Commission/SC Idle No More |
| 5:10–5:20 | Stel Bailey, Fight For Zero |
| 5:20–5:45 | Panel Discussion |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
| 5:40–5:45 | Break |
SESSION F—OPEN COMMENT PERIOD
| 5:45–6:45 | Public Comments |
| 6:45 | ADJOURN |
MAY 6, 2021
MIDDLE COMMUNITIES TOWN HALL (ATSDR REGIONS V–VII)
VIRTUAL MEETING
| 3:00–3:10 | Welcome and Introductions Bruce N. Calonge, Committee Chair |
SESSION A—Community Perspectives from ATSDR Region V
| 3:10–3:55 | Community Perspectives from ATSDR Region V Phil Brown, Moderator, Northeastern University Andi Rich, Save Our Water (S.O.H20) Laura Olah, Citizens for Safe Water Around Badger (CSWAB) Samraa Luqman, Concerned Residents for South Dearborn Cathy Wusterbarth, Need Our Water (NOW) |
| 3:55–4:15 | Panel Discussion with Session B Speakers |
SESSION B—Community Perspectives from ATSDR Region V (continued)
| 4:15–4:50 | Community Perspectives from ATSDR Region V Courtney Carignan, Moderator, Michigan State University Sandy Wynn-Stelt, Belmont, Michigan, resident Tom Johnson, Clean Water Action Vicki Quint, Foam Exposure Committee/Code PFAS |
| 4:50–5:10 | Panel Discussion |
| 5:10–5:20 | Break |
SESSION C—Community Perspectives from ATSDR Region VI and VII
| 5:20–5:55 | Community Perspectives from ATSDR Regions VI and VII Alan Ducatman, Moderator, West Virginia University Art Schaap, Highland Dairy, Cedar Rapids, Iowa Resident John Kern, Clean Water Partnership |
| 5:55–6:15 | Panel Discussion |
| 6:15–6:20 | Break |
| 6:20–7:00 | Public Comments |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
| 7:00 | ADJOURN |
MAY 25, 2021
WESTERN COMMUNITIES TOWN HALL (ATSDR REGIONS VIII–X)
VIRTUAL MEETING
| 1:00–1:10 | Welcome and Introductions Bruce N. Calonge, Committee Chair |
SESSION A—Community Perspectives from ATSDR Region VIII and IX
| 1:10–2:00 | Community Perspectives from ATSDR Region VIII and IX Elizabeth Neary, Moderator, Wisconsin Environmental Health Network Liz Rosenbaum, Fountain Valley Clean Water Coalition Martha Dina Argüello, Physicians for Social Responsibility, Los Angeles Mark A. Favors, Army Veteran |
| 1:40–2:00 | Panel Discussion |
SESSION B—Community Perspectives from ATSDR Region IX
| 2:00–2:30 | Community Perspectives from ATSDR Region IX Lenny Siegel, Moderator, Center for Public Environmental Oversight Andria Ventura, Clean Water Action Fund Linda Shosie, Environmental Justice Task Force, Tucson, Arizona Aaron Maruzzo, University of California, Berkeley, School of Public Health |
| 2:30–2:50 | Panel Discussion |
| 2:50–3:00 | Break |
SESSION C—Community Perspectives from ATSDR Region X
| 3:00–3:30 | Community Perspectives from ATSDR Region X Anna Reade, Moderator, Natural Resources Defense Council Pamela Miller, Alaska Community Action on Toxics Randy Krause, Port of Seattle/Washington State Association of Fire Chiefs Jean Mendoza, Friends of Toppenish Creek |
| 3:30–3:50 | Panel Discussion |
SESSION D—Additional Community Perspectives
| 3:50–4:20 | Additional Community Perspectives Celeste Anne Monforton, Moderator, Texas State University Rebecca Patterson, Vietnam Veterans of America Bucky Bailey, Son of former DuPont Washington Works plant employee |
| 4:20–4:40 | Panel Discussion with Session E Speakers |
| 4:40–4:45 | Break |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
| 4:45–5:00 | Public Comments |
| 5:00 | ADJOURN |
JULY 13–14, 2021
INFORMATION-GATHERING SESSION, MEETING 5
VIRTUAL MEETING
Thursday, July 13, 2021
| 1:30–1:40 | Welcome and Introductions Bruce N. Calonge, Committee Chair |
SESSION A—Patient Perspectives on PFAS Testing and Health Outcomes
| 1:40–1:55 | Patient Perspectives on PFAS Testing and Health Outcomes Andrea Amico, Testing for Pease |
SESSION B—Human Exposure Sources
| 1:55–2:25 | Current Knowledge About the Contribution of PFAS Exposure Sources to Human Exposure Elsie M. Sunderland, Harvard University |
| 2:25–2:55 | Panel Reflection and Q&A from Committee Chris Wiant, Moderator, Committee Member Bruce H. Alexander, Colorado State University Thomas F. Webster, Boston University School of Public Health Laurel Schaider, Silent Spring Institute Elsie M. Sunderland, Harvard University |
| 2:55–3:05 | Break |
SESSION C—Human Exposure Reduction
| 3:05–3:35 | Clinical Principles for Advising Patients to Reduce Exposure Sheela Sathyanarayana, University of Washington |
| 3:35–4:05 | Panel Reflection and Q&A from Committee Brian Linde, Moderator, Committee Member Judy LaKind, LaKind Associates Andrea Amico, Testing for Pease Sheela Sathyanarayana, University of Washington |
| 4:05–4:35 | Open Comment Period |
| 4:35 | ADJOURN |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
HEALTH EFFECTS
Wednesday, July 14, 2021
| 1:00–1:10 | Welcome, Purpose of Open Session Bruce N. Calonge, Committee Chair |
SESSION D—Overview of Putative Health Effects
| 1:00–2:10 | Epidemiology: David Savitz, Brown University Toxicology: Jamie DeWitt, East Carolina University |
| 2:10–2:40 | Panel Reflection and Q&A from Committee Jane Hoppin, Moderator, Committee Member Linda Birnbaum, National Institute of Environmental Health Sciences, National Toxicology Program (retired) Joseph M. Braun, Brown University Matthew Longnecker, Ramboll David Savitz, Brown University Jamie Dewitt, East Carolina University |
| 2:40–2:55 | Break |
SESSION E—Evidence Synthesis and Its Application
| 2:55–3:25 | Methods for Evidence Synthesis Jonathan Samet, Colorado School of Public Health |
| 3:25–3:55 | Making Useful Recommendations Rebecca L. Morgan, McMaster University |
| 3:55–4:25 | Panel Reflection and Q&A from Committee Bruce N. Calonge, Moderator, Committee Member Ellen Chang, Exponent Nicholas Chartres, University of California, San Francisco Holger Schünemann, McMaster University Rebecca L. Morgan, McMaster University Jonathan Samet, Colorado School of Public Health |
| 4:25–4:55 | Open Comment Period |
| 4:55 | ADJOURN |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
AUGUST 11–12, 2021
INFORMATION-GATHERING SESSION, MEETING 6
VIRTUAL MEETING
Wednesday, August 11, 2021
| 1:25–1:35 | Welcome and Introductions Bruce N. Calonge, Committee Chair |
SESSION A—Frameworks for Making Decisions on Clinical Evaluation and Biomonitoring
| 1:35–2:05 | Principles for Making Decisions on Clinical Evaluation and Biomonitoring David Resnik, National Institute of Environmental Health Sciences |
| 2:05–2:35 | Application of Decision-Making Framework in the C-8 Medical Monitoring Panel Dean Baker, University of California, Irvine |
| 2:35–3:05 | Panel Reflection and Q&A from Committee Kevin Elliott, Moderator Courtney Carignan, Michigan State University Ayesha Khan, Nantucket PFAS Action Group Jeffrey Brent, University of Colorado Dean Baker, University of California, Irvine David Resnik, National Institute of Environmental Health Sciences |
SESSION B—Clinician Perspective on Advising Patients in PFAS-Exposed Communities
| 3:05–3:25 | Clinician Perspective on Advising Patients in PFAS-Exposed Communities Alan Ducatman, West Virginia University |
| 3:25–3:55 | Panel Discussion with Clinicians Who Have Advised Patients in PFAS-Exposed Communities Laura Anderko, Moderator Katie Huffling, Alliance of Nurses for Healthy Environments Stewart Reed, University of California, Los Angeles Maida Galvez, Icahn School of Medicine at Mount Sinai Hospital Alan Ducatman, West Virginia University |
| 3:55–4:25 | Open Comment Period |
| 4:25 | ADJOURN |
Thursday, August 12, 2021
| 1:00–1:10 | Welcome, Purpose of Open Session Bruce N. Calonge, Committee Chair |
Suggested Citation:
"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
doi: 10.17226/26156.
SESSION C—Clinical Principles for Communicating Biomonitoring Results and Relationship with Clinical Care
| 1:10–1:40 | Biomonitoring Results: Communication Julia Brody, Silent Spring Institute |
| 1:40–1:55 | PFAS Clinical Guidance Phil Brown, Northeastern University |
| 1:55–2:25 | Panel Reflection and Q&A from Committee Erin Haynes, Moderator, Committee member Marc A. Nascarella, Massachusetts Department of Public Health Jessica Nelson, Minnesota Department of Health Gary Ginsberg, New York Department of Health Julia Brody, Silent Spring Institute Phil Brown, Northeastern University |
| 2:25–2:55 | Open Comment Period |
| 2:55 | ADJOURN |
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.